Cross-Linked Potato Starch for Pharma from Canada
Cross-linked modified potato starch used as disintegrant in pharmaceutical tablets, not a finished medicament. Under HTS 3505.10.0045 as potato-derived modified starch, excluding chapter 30 products. Low reducing sugar confirms dextrin status.
Duty Rate — Canada → United States
60%
Rate breakdown
9903.03.1450%Articles the product of Canada as provided in subdivision (b)(3) of U.S. note 51 to this subchapter
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• FDA/USP compliance docs essential; affirm not 'prepared for therapeutic use' per chapter note
• Lab reports on cross-linking and potato source to prevent reclass to medicaments
• For pharma import, align with drug master files but classify as raw material